Last reviewed · How we verify

NCT05467527

PACT Programme for Parents of Children With SHCN

Recruiting now NA Last updated 13 August 2025
What this trial tests

NA trial testing Prosocial-orientated Acceptance and Commitment Training plus positive parenting advice in Urologic Diseases in 196 participants. Currently enrolling.

Timeline
27 June 2022
Primary endpoint
30 November 2025
31 December 2025

Quick facts

Lead sponsorChinese University of Hong Kong
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment196
Start date27 June 2022
Primary completion30 November 2025
Estimated completion31 December 2025
Sites2 locations across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

21 and older, any sex, with Urologic Diseases or Gastrointestinal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomised controlled trial aims to determine the efficacy of a 12-week, smartphone-based Prosocial-orientated Acceptance and Commitment Training (PACT) programme plus age-appropriate positive parenting advice on the psychological flexibility, prosociality, parenting competence and family functioning with parents of children with special health care needs as well as the mental well-being of parent-child dyads over 12 months follow-up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Urologic Diseases

Currently open trials in the same condition.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05467527.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing